Jiangang Liu

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Eli Lilly and Company

Indiana University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Eli Lilly and Company Jan 11 1999

United States

Senior Research Scientist :: Oncology

Education History

Indiana University Aug 04 2004 - Dec 31 2010

United States

PHD :: School of Informatics

Publications

Jiangang Liu, David S Moura, Robin L Jones, Amit Aggarwal, Philip J Ebert, Andrew J Wagner, Jennifer Wright, Javier Martín-Broto, William D Tap
Best Overall Response-associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCE. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Jiangang Liu, David S Moura, Robin L Jones, Amit Aggarwal, Philip J Ebert, Andrew J Wagner, Jennifer Wright, Javier Martín-Broto, William D Tap
Best Overall Response-Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCE. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Sara M Tolaney, Shom Goel, Jorge Nadal, Hannelore G Denys, Manuel Ruiz Borrego, Lacey M Litchfield, Jiangang Liu, Adams K Appiah, Yanyun Chen, Fabrice Andre
Overall survival and exploratory biomarker analyses of abemaciclib plus trastuzumab with or without fulvestrant vs trastuzumab plus chemotherapy in HR+, HER2+ metastatic breast cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Alyssa C Flint, Dana K Mitchell, Steven P Angus, Abbi Elise Smith, Waylan Bessler, Li Jiang, Henry Elmer Mang, Xiaohong Li, Qingbo Lu, Brooke E Hickey, George E Sandusky, Andrea R Masters, Chi Zhang, Pengtao Dang, Jenna K Koenig, Gary L Johnson, Weihua Shen, Jiangang Liu, Amit Aggarwal, Gregory P Donoho, Melinda D Willard, Shripad V Bhagwat, D Wade Clapp, Steven D Rhodes
Combined CDK4/6 and ERK1/2 inhibition enhances anti-tumor activity in NF1-associated plexiform neurofibroma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Carmine De Angelis, Xiaoyong Fu, Maria Letizia Cataldo, Agostina Nardone, Resel Pereira, Jamunarani Veeraraghavan, Sarmistha Nanda, Lanfang Qin, Vidyalakshmi Sethunath, Nicholas Wang, Susan G Hilsenbeck, Matteo Benelli, Ilenia Migliaccio, Cristina Guarducci, Luca Malorni, Lacey M Litchfield, Jiangang Liu, Joshua Donaldson, Pier Selenica, David N Brown, Britta Weigelt, Jorge S Reis-Filho, Ben H Park, Sara A Hurvitz, Dennis J Slamon, Mothaffar F Rimawi, Valerie M Jansen, Rinath M Jeselsohn, C Kent Osborne, Rachel Schiff
Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (17) (2021)
Sara A Hurvitz, Miguel Martin, Michael F Press, David Chan, María Fernandez-Abad, Edgar Petru, Regan Rostorfer, Valentina Guarneri, Chiun-Sheng Huang, Susana Barriga, Sameera Wijayawardana, Manisha Brahmachary, Philip J Ebert, Anwar Hossain, Jiangang Liu, Adam Abel, Amit Aggarwal, Valerie M Jansen, Dennis J Slamon
Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR+/HER2- Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (3) (2019)

Jiangang Liu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jiangang Liu